tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VKTX Stock Latest News

Viking Therapeutics participates in a conference call with Maxim Group
The FlyViking Therapeutics participates in a conference call with Maxim Group
20h ago
VKTX
Promising Developments and Strong Financial Position Bolster Buy Rating for Viking Therapeutics
PremiumRatings
Promising Developments and Strong Financial Position Bolster Buy Rating for Viking Therapeutics
1d ago
VKTX
Viking Therapeutics: Promising Pipeline and Strategic Execution Drive Buy Rating
PremiumRatings
Viking Therapeutics: Promising Pipeline and Strategic Execution Drive Buy Rating
1d ago
VKTX
Viking Therapeutics price target lowered to $85 from $96 at B. Riley
PremiumThe Fly
Viking Therapeutics price target lowered to $85 from $96 at B. Riley
2d ago
VKTX
Viking Therapeutics: Strong Financials and Promising VK2735 Program Drive Buy Rating
PremiumRatings
Viking Therapeutics: Strong Financials and Promising VK2735 Program Drive Buy Rating
2d ago
VKTX
Viking Therapeutics Advances Clinical Pipeline in Q1 2025
PremiumCompany AnnouncementsViking Therapeutics Advances Clinical Pipeline in Q1 2025
3d ago
VKTX
Promising Developments and Financial Stability Underpin Buy Rating for Viking Therapeutics
Premium
Ratings
Promising Developments and Financial Stability Underpin Buy Rating for Viking Therapeutics
3d ago
VKTX
Viking Therapeutics reports Q1 EPS (41c), consensus (31c)
Premium
The Fly
Viking Therapeutics reports Q1 EPS (41c), consensus (31c)
3d ago
VKTX
Viking Therapeutics options imply 8.5% move in share price post-earnings
PremiumThe Fly
Viking Therapeutics options imply 8.5% move in share price post-earnings
3d ago
VKTX
Viking Therapeutics price target lowered to $100 from $164 at Oppenheimer
PremiumThe Fly
Viking Therapeutics price target lowered to $100 from $164 at Oppenheimer
3d ago
VKTX
VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
VKTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5d ago
VKTX
Buy Rating for Viking Therapeutics Driven by Promising VK2735 Oral GLP-1 Agonist Potential
PremiumRatings
Buy Rating for Viking Therapeutics Driven by Promising VK2735 Oral GLP-1 Agonist Potential
9d ago
VKTX
H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data
PremiumThe FlyH.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data
9d ago
LLY
VKTX
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
Premium
The Fly
Eli Lilly jumps as results from weight-loss pill study rival competitor’s
9d ago
LLY
NVO
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
Premium
The Fly
JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics
9d ago
LLY
GPCR
Viking Therapeutics slips after Eli Lilly reports orforglipron trial results
PremiumThe Fly
Viking Therapeutics slips after Eli Lilly reports orforglipron trial results
9d ago
LLY
VKTX
Viking Therapeutics’ VK2735: A Promising Contender Amidst Pfizer’s Setback
PremiumRatings
Viking Therapeutics’ VK2735: A Promising Contender Amidst Pfizer’s Setback
10d ago
VKTX
Promising Pipeline and Strategic Developments Drive Buy Rating for Viking Therapeutics
PremiumRatings
Promising Pipeline and Strategic Developments Drive Buy Rating for Viking Therapeutics
11d ago
VKTX
Viking Therapeutics’ VK2735 Gains Buy Rating Amid Pfizer’s GLP-1 Drug Halt and Promising Trial Results
PremiumRatings
Viking Therapeutics’ VK2735 Gains Buy Rating Amid Pfizer’s GLP-1 Drug Halt and Promising Trial Results
11d ago
VKTX
BTIG highlights some reasons to own Viking shares after danuglipron discontinued
PremiumThe FlyBTIG highlights some reasons to own Viking shares after danuglipron discontinued
12d ago
PFE
VKTX
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
Premium
The Fly
Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill
12d ago
LLY
NVO
JPMorgan says Pfizer news ‘mostly a positive’ for Structure, Viking
Premium
The Fly
JPMorgan says Pfizer news ‘mostly a positive’ for Structure, Viking
12d ago
PFE
GPCR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >